Full Length Research Paper
References
Aghamohammadi A, Zafari M, Tofighi M (2011). High maternal hemoglobin concentration in first trimester as risk factor for pregnancy induced hypertension. Caspian J. Intern. Med. 2(1):194-197. |
|
Burgess A, Founds S (2016). Cardiovascular implications of preeclampsia. Am. J. Matern. Child Nurs. 41(1):8-15. |
|
Daniel WW (1999). Biostatistics: A Foundation for Analysis in the Health Sciences. 7th edition. New York: John Wiley & Sons. |
|
De Vera MA, Berard A (2012). Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension. Br. J. Clin. Pharmacol. 74(2):362-369. |
|
Ferrer RL, Sibai BM, Mulrow CD (2000). Management of mild chronic hypertension during pregnancy: A review. Obstet. Gynecol. 96:849- 860. |
|
Garg AX, Nevis IF, McArthur E, Sontrop JM, Koval JJ, Lam NN, Hildebrand AM, Reese PP, Storsley L, Gill JS, Segev DL, Habbous S, Bugeja A, Knoll GA, Dipchand CM, Cuadros M, Lentine KL (2014). "Gestational Hypertension and Preeclampsia in Living Kidney Donors". New Engl. J. Med. 372(45):4790-4793. |
|
Heidrich MB, Wenzel D, von Kaisenberg CS, Schippert C, von Versen-Hoynck FM (2013). Preeclampsia and long-term risk of cardiovascular disease: what do obstetrician-gynecologists know? - BMC Pregnancy and Childbirth 9:13:61. |
|
Hollegaard B, Byars SG, Lykke J, Boomsma JJ (2013). Parent-Offspring Conflict and the Persistence of Pregnancy-Induced Hypertension in Modern Humans. PLoS ONE. 8(2):e56821. |
|
Imes CC, Lewis FM, Austin MA, Dougherty CM (2015). My family medical history and me: feasibility results of a cardiovascular risk reduction intervention. Public Health Nurs. 32(3):246-255. |
|
Katon WJ, Russo JE, Melville JL, Katon JG, Gavin AR (2012). Depression in pregnancy is associated with preexisting but not pregnancy-induced hypertension. Gen. Hosp. Psychiatr. 34(1):9-16. |
|
Kintiraki E, Papakatsika S, Kotronis G, Goulis DG, Kotsis V (2015). Pregnancy-Induced hypertension. Hormones 14(2):211-223. |
|
Lo JO, Mission JF, Caughey AB (2013). Hypertensive disease of pregnancy and maternal mortality. Curr. Opin. Obstet. Gynecol. 25(2):124-32. |
|
Mehta PK, Minissian M, Bairey Merz CN (2015). Adverse pregnancy outcomes and cardiovascular risk factor management. Seminars perinatol. 39(4):268-275. |
|
Osungbade KO, Ige OK (2011). Public health perspectives of preeclampsia in developing countries: implication for health system strengthening. J. Pregnancy 481095. |
|
Pieper PG, Lameijer H, Hoendermis ES (2014). Pregnancy and pulmonary hypertension. Best Practice and Research: Clinical Obstetrics Gynaecol. 28(4):579-591. |
|
Repke JT, Power ML, Holzman GB, Suhulklin J (2002). Hypertension in pregnancy and preeclampsia. Knowledge and clinical practice among obstetrician-gynecologists. J. Reprod. Med. 47(6):472-476. |
|
Sajith M, Nimbargi V, Modi A, Sumariya R (2014). Incidence of pregnancy induced hypertension and prescription pattern of antihypertensive drugs in pregnancy. Int. J. Pharm. Sci. Res. (IJPSR). 5(4):163-170. |
|
Seely EW, Rich-Edwards J, Lui J, Nicklas JM, Saxena A, Tsigas E, Levkoff SE (2013). Risk of future cardiovascular disease in women with prior preeclampsia: A focus group study. BMC Pregnancy Childbirth 21:13-240. |
|
Seely EW, Tsigas E, Rich-Edwards JW (2015). Preeclampsia and future cardiovascular disease in women: How good are the data and how can we manage our patients? Semin. Perinatol. 39(4):276-283. |
|
Solomon CG, Seely EW (2011). Hypertension in pregnancy. Endocrinol. Metab. Clin. North Am. 10(8):120-125. |
|
Spratling PM, Pryor ER, Moneyham LD, Hodges AL, White-Williams CL, Martin JN Jr (2014). Effect of an educational intervention on cardiovascular disease risk perception among women with preeclampsia. J. Obstet. Gynaecol. Neonatal Nurs. 43(2):179-189. |
|
Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010). Pre-eclampsia. Lancet 376(9741):631-644. |
|
Suzuki Y, Matsuura A, Yamamoto T (2015). Management of pregnancy induced hypertension. Nihon Rinsho. Japanese J. Clin. Med. 73(11):1897-1903. |
|
van Middendorp D, ten Asbroek A, Bio FY, Edusei A, Meijjer L, Newton S, Agyemang C (2013). Rural and urban differences in blood pressure and pregnancy-induced hypertension among pregnant women in Ghana. Glob. Health 9(1):59. |
|
Veerbeek JH, Hermes W, Breimer AY, Van Rijn BB, Koenen SV, Mol BW, Koster MP (2015). Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension 65(3):600-606. |
|
Vest AR, Cho LS (2014). Hypertension in pregnancy. Curr. Atheroscler. Rep. 13(6):95-98. |
|
World Health Organization (WHO) (2011). WHO Recommendations for prevention and treatment of pre-eclampsia and eclampsia. Available at: |
|
You WB, Wolf M, Bailey SC, Pandit AU, Waite KR, Sobel RM, Grobman W (2012a). Factors associated with patient understanding of preeclampsia. Hypertens. pregnancy 31(3):341-349. |
|
You WB, Wolf MS, Bailey SC, Grobman WA (2012b). Improving patient understanding of preeclampsia: a randomized controlled trial. Am. J. Obstet. Gynecol. 206(5):431-e1. |
|
Young B, Hacker MR, Rana S (2012). Physicians' knowledge of future vascular disease in women with preeclampsia. Hypertens. pregnancy 31(1):50-58. |
|
Zoet GA, Koster MP, Velthuis BK, de Groot CJ, Maas AH, Fauser BC,Franx A, van Rijn BB (2015). Determinants of future cardiovascular health in women with a history of preeclampsia. Maturitas 82(2):153-161. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0